Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marty Makary
Fierce Pharma
FDA approves leucovorin without clinical trial—but not for autism
The FDA has used real-world data to approve leucovorin to treat cerebral folate deficiency in patients who have a confirmed variant in the FOLR1 gene.
Angus Liu
,
Darren Incorvaia
Mar 10, 2026 9:00am
CBER Director Vinay Prasad to depart FDA—again
Mar 6, 2026 5:30pm
Senior FDA official fires back at uniQure amid controversy
Mar 5, 2026 3:33pm
Senate hearing takes aim at FDA's rare disease review process
Feb 26, 2026 3:50pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
Disc's rare disease drug hit by FDA rejection
Feb 13, 2026 5:00pm